AAAAAA

   
Results: 1-9 |
Results: 9
Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides
Authors: Mohan, N Edwards, ET Cupps, TR Oliverio, PJ Sandberg, G Crayton, H Richert, JR Siegel, JN
Citation: N. Mohan et al., Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides, ARTH RHEUM, 44(12), 2001, pp. 2862-2869
Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis
Authors: Fischer, JS Priore, RL Jacobs, LD Cookfair, DL Rudick, RA Herndon, RM Richert, JR Salazar, AM Goodkin, DE Granger, CV Simon, JH Grafman, JH Lezak, MD Hovey, KMO Perkins, KK Barilla-Clark, D Schacter, M Shucard, DW Davidson, AL Wende, KE Bourdette, DN Kooijmans-Coutinho, MF
Citation: Js. Fischer et al., Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis, ANN NEUROL, 48(6), 2000, pp. 885-892
EAE susceptibility in FVB mice
Authors: Baker, AM Grekova, MC Richert, JR
Citation: Am. Baker et al., EAE susceptibility in FVB mice, J NEUROSC R, 61(2), 2000, pp. 140-145
Localization of the human SP3 gene to chromosome 7p14-p15.2. The lack of expression in multiple sclerosis does not reflect abnormal gene organization
Authors: Grekova, MC Scherer, SW Trabb, J Richert, JR
Citation: Mc. Grekova et al., Localization of the human SP3 gene to chromosome 7p14-p15.2. The lack of expression in multiple sclerosis does not reflect abnormal gene organization, J NEUROIMM, 106(1-2), 2000, pp. 214-219
A longitudinal study of T1 hypointense lesions in relapsing MS - MSCRG trial of interferon beta-1a
Authors: Simon, JH Lull, J Jacobs, LD Rudick, RA Cookfair, DL Herndon, RM Richert, JR Salazar, AM Sheeder, J Miller, D McCabe, K Serra, A Campion, MK Fischer, JS Goodkin, DE Simonian, N Lajaunie, M Wende, K Martens-Davidson, A Kinkel, RP Munschauer, FE
Citation: Jh. Simon et al., A longitudinal study of T1 hypointense lesions in relapsing MS - MSCRG trial of interferon beta-1a, NEUROLOGY, 55(2), 2000, pp. 185-192
Cerebrospinal fluid abnormalities in a phase III trial of Avonex (R) (IFN beta-1a) for relapsing multiple sclerosis
Authors: Rudick, RA Cookfair, DL Simonian, NA Ransohoff, RM Richert, JR Jacobs, LD Herndon, RM Salazar, AM Fischer, JS Granger, CV Goodkin, DE Simon, JH Bartoszak, DM Bourdette, DN Braiman, J Brownscheidle, CM Coats, ME Cohan, SL Dougherty, DS Kinkel, RP Mass, MK Munchsauer, FE O'Reilly, K Priore, RL Pullicino, PM Scherokman, BJ Wende, K Weinstock-Guttman, B Whitham, RH
Citation: Ra. Rudick et al., Cerebrospinal fluid abnormalities in a phase III trial of Avonex (R) (IFN beta-1a) for relapsing multiple sclerosis, J NEUROIMM, 93(1-2), 1999, pp. 8-14
A longitudinal study of brain atrophy in relapsing multiple sclerosis
Authors: Simon, JH Jacobs, LD Campion, MK Rudick, RA Cookfair, DL Herndon, RM Richert, JR Salazar, AM Fischer, JS Goodkin, DE Simonian, N Lajaunie, M Miller, DE Wende, K Martens-Davidson, A Kinkel, RP Munschauer, FE Brownscheidle, CM
Citation: Jh. Simon et al., A longitudinal study of brain atrophy in relapsing multiple sclerosis, NEUROLOGY, 53(1), 1999, pp. 139-148
Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials
Authors: Goodkin, DE Priore, RL Wende, KE Campion, M Bourdette, DN Herndon, RM Fischer, JS Jacobs, LD Cookfair, DL Rudick, RA Richert, JR Salazar, AM Granger, CV Simon, JH Alam, JJ Bartoszak, DM Braiman, J Brownscheidle, CM Coats, ME Cohan, SL Dougherty, DS Kinkel, RP Mass, MK Munschauer, FE Pullicino, PM Scherokman, BJ Weinstock-Guttman, B Whitham, RH
Citation: De. Goodkin et al., Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials, MULT SCLER, 4(6), 1998, pp. 480-486
Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminaryreport
Authors: Ablashi, DV Lapps, W Kaplan, M Whitman, JE Richert, JR Pearson, GR
Citation: Dv. Ablashi et al., Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminaryreport, MULT SCLER, 4(6), 1998, pp. 490-496
Risultati: 1-9 |